Clinical Trial Evaluates CXCR2 Antagonist AZD5069 Effect on Neutrophil Recruitment in Bronchiectasis
News
In a new study entitled “A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis”, researchers performed a randomized, double-blind, placebo-controlled study to determine the effect of CXCR2 antagonist AZD5069 ... Read more